Feedback / Questions
NECVAX NEO1 - NEC Corp
https://www.newswiretoday.com/news/185270/NEC-Presents-Phase-I-Results-for-Personalized-AI-Powered-Oral-Cancer-Vaccine-NECVAX-NEO1-at-ESMO-Immuno-Oncology-Congress-2025/
Dec 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next